z-logo
open-access-imgOpen Access
Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database
Author(s) -
Lily E. Johnston,
Hop S. Tran Cao,
David C. Chang,
Michael Bouvet
Publication year - 2012
Publication title -
isrn endocrinology
Language(s) - English
Resource type - Journals
eISSN - 2090-4649
pISSN - 2090-4630
DOI - 10.5402/2012/384707
Subject(s) - medicine , malignancy , epidemiology , marital status , ethnic group , multivariate analysis , hazard ratio , proportional hazards model , thyroid cancer , cancer , surveillance, epidemiology, and end results , stage (stratigraphy) , oncology , demography , cancer registry , population , confidence interval , biology , environmental health , paleontology , sociology , anthropology
Background . Differentiated thyroid carcinoma (DTC) is prognosticated upon a combination of tumor characteristics, such as histology and stage, and patient age. DTC is also notable for having a strong female predominance. Using a nationwide database with long follow-up times, we explored the interplay between tumor biology and patient characteristics in predicting mortality. Methods . The Surveillance, Epidemiology, and End Results (SEER) registry data 1973–2005 was examined for patients with DTC as their only known malignancy. Cox multivariate analyses were used to generate mortality hazard ratios to evaluate the effects of age, gender, ethnicity, and marital status. Results . We identified 55,995 patients with DTC as their only malignancy. Consistent with the existing literature, the tumors are primarily diagnosed in women (77.5%), and predominantly affect Caucasians (78.3%). Female gender had a protective effect resulting in a 37% decrease in mortality. Age at diagnosis predicted mortality over age 40. Black ethnicity was associated with a 51% increase in mortality compared to Caucasians. Conclusion . Multiple demographic factors predict mortality in patients with DTC after adjusting for tumor characteristics, and they appear to have complex interactions. Recognizing the importance of these factors may enable clinicians to better tailor therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom